Effect of pre-transplantation serum ferritin on outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation: A meta-analysis
- PMID: 29979374
- PMCID: PMC6076067
- DOI: 10.1097/MD.0000000000010310
Effect of pre-transplantation serum ferritin on outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation: A meta-analysis
Abstract
Background: Pre-transplantation serum ferritin (SF) has been considered to be a potential prognostic biomarker in patients undergoing allogeneic hematopoietic stem cell transplantation (allogeneic HSCT), but this conclusion remains controversial. Thus, we performed a meta-analysis to investigate the prognostic significance of pre-transplantation SF in patients undergoing allogeneic HSCT.
Methods: We systematically searched PubMed, Embase, and Web of Science up to September 2017, and finally identified a total of 25 eligible studies with 4545 patients.
Results: The pooled results of our meta-analysis showed that high pre-transplantation SF was markedly related to worse overall survival (OS) [hazard ratio (HR) = 1.82; 95% confidence interval (95% CI): 1.47-2.26; P < .001], nonrelapse mortality (NRM) (HR = 2.28; 95% CI: 1.79-2.89; P < .001), and progression-free survival (PFS) (HR = 1.72; 95% CI: 1.27-2.33; P < .001). In addition, high pre-transplantation SF was closely associated with a lower incidence of chronic graft versus host disease (cGVHD) (OR = 0.74, 95% CI: 0.58-0.96; P < .05), and a higher incidence of blood stream infections (BSIs) (OR = 1.67, 95% CI: 0.93-3.01; P = .09). However, no significance relationship was found between elevated pre-transplantation SF and acute graft versus host disease (aGVHD) (OR = 1.08, 95% CI:.72-1.62; P = .70).
Conclusion: In patients undergoing allogeneic HSCT for hematological malignancies, elevated pre-transplantation SF was significantly associated with worse OS and PFS, higher incidence of NRM and BSI, and lower incidence of cGVHD, but it had no effect on aGVHD. Considering the limitations in our meta-analysis, more prospective and homogeneous clinical studies are needed to further confirm our findings.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/6c990e8dc586/medi-97-e10310-g001.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/7331b64d7127/medi-97-e10310-g005.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/da836d0dfd60/medi-97-e10310-g007.gif)
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/60b22fcf49e4/medi-97-e10310-g009.gif)
![Figure 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/a652f4cf1f5a/medi-97-e10310-g011.gif)
![Figure 6](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/96d7ac04efd8/medi-97-e10310-g012.gif)
![Figure 7](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/b33982c674fb/medi-97-e10310-g013.gif)
![Figure 8](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/7e7b207d497d/medi-97-e10310-g014.gif)
![Figure 9](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ad/6076067/6e8c8752dee2/medi-97-e10310-g015.gif)
Similar articles
-
Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant. 2009 Feb;15(2):195-204. doi: 10.1016/j.bbmt.2008.11.012. Biol Blood Marrow Transplant. 2009. PMID: 19167679
-
Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.Neoplasma. 2012;59(2):183-90. doi: 10.4149/neo_2012_024. Neoplasma. 2012. PMID: 22248276
-
Clinical significance of pre- and 1-year post-transplant serum ferritin among adult transplant recipients.Leuk Lymphoma. 2014 Jun;55(6):1350-6. doi: 10.3109/10428194.2013.842981. Epub 2013 Nov 1. Leuk Lymphoma. 2014. PMID: 24024470
-
Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2019 Feb;98(8):e14474. doi: 10.1097/MD.0000000000014474. Medicine (Baltimore). 2019. PMID: 30813150 Free PMC article. Review.
-
Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.Front Immunol. 2020 Aug 18;11:1854. doi: 10.3389/fimmu.2020.01854. eCollection 2020. Front Immunol. 2020. PMID: 33013836 Free PMC article. Review.
Cited by
-
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.Front Immunol. 2020 Apr 15;11:586. doi: 10.3389/fimmu.2020.00586. eCollection 2020. Front Immunol. 2020. PMID: 32351502 Free PMC article.
-
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation.EJHaem. 2022 Nov 7;4(1):192-198. doi: 10.1002/jha2.586. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819160 Free PMC article.
-
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2020 Sep;26(9):1697-1703. doi: 10.1016/j.bbmt.2020.06.002. Epub 2020 Jun 11. Biol Blood Marrow Transplant. 2020. PMID: 32534103 Free PMC article.
-
The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis.Medicine (Baltimore). 2019 Oct;98(40):e17406. doi: 10.1097/MD.0000000000017406. Medicine (Baltimore). 2019. PMID: 31577751 Free PMC article.
-
The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.Front Immunol. 2021 Feb 19;11:627662. doi: 10.3389/fimmu.2020.627662. eCollection 2020. Front Immunol. 2021. PMID: 33679722 Free PMC article. Review.
References
-
- Jastaniah W, Harmatz P, Pakbaz Z, et al. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer 2008;50:319–24. - PubMed
-
- Kataoka K, Nannya Y, Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009;15:195–204. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources